245 related articles for article (PubMed ID: 21194405)
21. Pulmonary hypertension secondary to chronic obstructive pulmonary disease.
Gologanu D; Stanescu C; Bogdan MA
Rom J Intern Med; 2012; 50(4):259-68. PubMed ID: 23610973
[TBL] [Abstract][Full Text] [Related]
22. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
Adnot S; Samoyeau R; Weitzenblum E
Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective.
Minai OA; Chaouat A; Adnot S
Chest; 2010 Jun; 137(6 Suppl):39S-51S. PubMed ID: 20522579
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension.
Hajian B; De Backer J; Vos W; Van Holsbeke C; Ferreira F; Quinn DA; Hufkens A; Claes R; De Backer W
Int J Chron Obstruct Pulmon Dis; 2016; 11():1533-41. PubMed ID: 27462149
[TBL] [Abstract][Full Text] [Related]
25. [Pulmonary hypertension and cor pulmonale in COPD].
Kuwahira I; Iwamoto T
Nihon Rinsho; 2003 Dec; 61(12):2138-43. PubMed ID: 14674323
[TBL] [Abstract][Full Text] [Related]
26. Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD.
Alqarni AA; Aldhahir AM; Alghamdi SA; Alqahtani JS; Siraj RA; Alwafi H; AlGarni AA; Majrshi MS; Alshehri SM; Pang L
Front Med (Lausanne); 2023; 10():1275684. PubMed ID: 37881627
[TBL] [Abstract][Full Text] [Related]
27. Cor pulmonale.
Weitzenblum E; Chaouat A
Chron Respir Dis; 2009; 6(3):177-85. PubMed ID: 19643833
[TBL] [Abstract][Full Text] [Related]
28. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
[TBL] [Abstract][Full Text] [Related]
29. Update on pulmonary hypertension complicating chronic obstructive pulmonary disease.
Jyothula S; Safdar Z
Int J Chron Obstruct Pulmon Dis; 2009; 4():351-63. PubMed ID: 19802350
[TBL] [Abstract][Full Text] [Related]
30. Treatment of acute exacerbations with non-invasive ventilation in chronic hypercapnic COPD patients with pulmonary hypertension.
Parola D; Romani S; Petroianni A; Locorriere L; Terzano C
Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):183-91. PubMed ID: 22428469
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment.
Wright JL; Levy RD; Churg A
Thorax; 2005 Jul; 60(7):605-9. PubMed ID: 15994270
[TBL] [Abstract][Full Text] [Related]
32. Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease.
Corte TJ; Wort SJ
Clin Sci (Lond); 2009 Mar; 116(6):493-5. PubMed ID: 19037879
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease.
Naeije R
Proc Am Thorac Soc; 2005; 2(1):20-2. PubMed ID: 16113464
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
Vizza CD; Hoeper MM; Huscher D; Pittrow D; Benjamin N; Olsson KM; Ghofrani HA; Held M; Klose H; Lange T; Rosenkranz S; Dumitrescu D; Badagliacca R; Claussen M; Halank M; Vonk-Noordegraaf A; Skowasch D; Ewert R; Gibbs JSR; Delcroix M; Skride A; Coghlan G; Ulrich S; Opitz C; Kaemmerer H; Distler O; Grünig E
Chest; 2021 Aug; 160(2):678-689. PubMed ID: 33581097
[TBL] [Abstract][Full Text] [Related]
35. Right heart function in COPD.
Macnee W
Semin Respir Crit Care Med; 2010 Jun; 31(3):295-312. PubMed ID: 20496299
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary hypertension in COPD.
Chaouat A; Naeije R; Weitzenblum E
Eur Respir J; 2008 Nov; 32(5):1371-85. PubMed ID: 18978137
[TBL] [Abstract][Full Text] [Related]
37. Sustained improvement with iloprost in a COPD patient with severe pulmonary hypertension.
Hegewald MJ; Elliott CG
Chest; 2009 Feb; 135(2):536-537. PubMed ID: 19201716
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary Hypertension in COPD: A Case Study and Review of the Literature.
Cassady SJ; Reed RM
Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31382489
[TBL] [Abstract][Full Text] [Related]
39. Potential Role of CT Metrics in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension.
Ando K; Kuraishi H; Nagaoka T; Tsutsumi T; Hoshika Y; Kimura T; Ienaga H; Morio Y; Takahashi K
Lung; 2015 Dec; 193(6):911-8. PubMed ID: 26453478
[TBL] [Abstract][Full Text] [Related]
40. Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.
Dournes G; Laurent F; Coste F; Dromer C; Blanchard E; Picard F; Baldacci F; Montaudon M; Girodet PO; Marthan R; Berger P
Am J Respir Crit Care Med; 2015 Jan; 191(1):63-70. PubMed ID: 25393421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
